Sector | Healthcare | Compare with Sector peers |
Industry | Medical Equipment/Supplies/Accessories | Compare with Industry peers |
Website | http://www.nureca.com | |
Market Cap | 275.35 Cr. | |
Enterprise Value(EV) | 219.39 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.82 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 334.98 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 57.20 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 197.20 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 1.40 | Calculated using Price: 275.35 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.00 Cr. | 10,000,175 Shares |
FaceValue | 10 | |
About Nureca Ltd. | ||
Nureca is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs. It enables its customers with tools to help them monitor chronic ailments and other diseases, to improve their lifestyle. It is a digital first company wherein it sells its products through online channel partners such as e-commerce players, distributors and retailer. Further, it also sells its products through its own website drtrust.in. |
1 Day |
|
+1.23% |
1 Week |
|
-3.68% |
1 Month |
|
-10.47% |
3 Month |
|
-28.75% |
6 Month |
|
-22.69% |
1 Year |
|
-17.11% |
2 Year |
|
-80.12% |
5 Year |
|
|
10 Year |
|
6 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 426.3 | 162.03 | 61.23 | 52.39 | 24.55 | -4.14 | |
Return on Capital Employed (%) | 255.06 | 179.97 | 56.7 | 67.61 | 33.57 | -5.17 | |
Return on Assets (%) | 44.35 | 40.78 | 22.3 | 41.38 | 20.33 | -3.62 |
Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 2 | 8 | 15 | 163 | 203 | 195 | 197 | |
Non Curr. Liab. | 0 | 0 | 9 | 3 | 4 | 0 | 0 | |
Curr. Liab. | 5 | 15 | 10 | 24 | 45 | 9 | 9 | |
Minority Int. | ||||||||
Equity & Liab. | 7 | 24 | 34 | 190 | 252 | 204 | 207 | |
Non Curr. Assets | 0 | 1 | 1 | 4 | 13 | 17 | 12 | |
Curr. Assets | 7 | 23 | 33 | 186 | 239 | 187 | 195 | |
Misc. Exp. not W/O | ||||||||
Total Assets | 7 | 24 | 34 | 190 | 252 | 204 | 207 |
Particulars | 7 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 20 | 62 | 99 | 213 | 256 | 111 | 96 | |
Other Income | 0 | 0 | 0 | 3 | 8 | 7 | 14 | |
Total Income | 20 | 62 | 99 | 216 | 263 | 118 | 110 | |
Total Expenditure | -16 | -53 | -90 | -152 | -200 | -126 | -105 | |
PBIDT | 4 | 9 | 10 | 64 | 63 | -8 | 5 | |
Interest | 0 | 0 | -1 | -2 | -1 | 0 | 0 | |
Depreciation | 0 | 0 | 0 | 0 | -1 | -2 | -2 | |
Taxation | -1 | -3 | -2 | -16 | -16 | 2 | -1 | |
Exceptional Items | ||||||||
PAT | 3 | 6 | 6 | 46 | 45 | -8 | 1 | |
Minority Interest | ||||||||
Share Associate | ||||||||
Other Related Items | ||||||||
Consolidated Net Profit | 3 | 6 | 6 | 46 | 45 | -8 | 1 | |
Adjusted EPS | 445 | 889 | 914 | 46 | 45 | -8 | 1 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | -8 | 35 | 1 | 10 | |
Cash Fr. Inv. | 0 | 0 | 0 | -110 | -3 | -16 | |
Cash Fr. Finan. | 0 | 0 | 8 | 92 | -7 | -2 | |
Net Change | 0 | 0 | 0 | 17 | -9 | -8 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 17 | 8 | 1 |
Tue, 02 Apr 2024
Press Release Nureca Limited has informed the Exchange regarding a press release dated April 02, 2024, titled "Nureca Limited's Dr Trust Recognized as a 'Well Known Trademark' by the Indian Trademark Registry". |
Wed, 27 Mar 2024
Trading Window Nureca Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
Wed, 27 Mar 2024
Trading Window-XBRL NURECA LIMITED has informed the Exchange about Closure of Trading Window |
Thu, 18 Apr 2024 |
Close Within 52 Week Low Zone |
High Decrease in 1 Month |
High Decrease in 3 Months |
High Decrease in 6 Months |
High Decrease in 2 Years |